| Karen M Hardart, MD | |
|
2000 Medical Pkwy, Ste 304, Annapolis, MD 21401-3742 | |
| (410) 573-9530 | |
| (410) 573-9569 |
| Full Name | Karen M Hardart |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 2000 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477556066 | NPI | - | NPPES |
| CY310007 | Other | MD | BCBS |
| 953000200 | Medicaid | MD | |
| 597410Y5Z | Other | MD | MEDICARE |
| 597410ZDWS | Other | MD | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | D0053246 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Medical Group, Llc | 2860447315 | 431 |
News Archive
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
People undergoing bisphosphonate therapy to prevent or treat osteoporosis (a thinning of the bones) may be unfamiliar with the drug and possible adverse side effects on oral health, according to a study in the May issue of The Journal of the American Dental Association.
Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases.
Jamie Scott, a Simon Fraser University professor and Canada Research Chair in molecular immunity, and three international collaborators are getting a hefty financial boost in their efforts to develop an effective HIV/AIDS vaccine.
› Verified 9 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
People undergoing bisphosphonate therapy to prevent or treat osteoporosis (a thinning of the bones) may be unfamiliar with the drug and possible adverse side effects on oral health, according to a study in the May issue of The Journal of the American Dental Association.
Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases.
Jamie Scott, a Simon Fraser University professor and Canada Research Chair in molecular immunity, and three international collaborators are getting a hefty financial boost in their efforts to develop an effective HIV/AIDS vaccine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen M Hardart, MD Po Box 12622, Belfast, ME 04915-4017 Ph: (410) 573-9530 | Karen M Hardart, MD 2000 Medical Pkwy, Ste 304, Annapolis, MD 21401-3742 Ph: (410) 573-9530 |
News Archive
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
People undergoing bisphosphonate therapy to prevent or treat osteoporosis (a thinning of the bones) may be unfamiliar with the drug and possible adverse side effects on oral health, according to a study in the May issue of The Journal of the American Dental Association.
Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases.
Jamie Scott, a Simon Fraser University professor and Canada Research Chair in molecular immunity, and three international collaborators are getting a hefty financial boost in their efforts to develop an effective HIV/AIDS vaccine.
› Verified 9 days ago
Richard G. Welch, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Pkwy, Ste 304, Annapolis, MD 21401 Phone: 410-573-9530 Fax: 410-573-9569 | |
Monica B Jones, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy Ste 200, Annapolis, MD 21401 Phone: 443-481-3493 Fax: 443-481-6705 | |
Dr. Joy'el B Ballard, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2000 Medical Pkwy, Ste. 304, Annapolis, MD 21401 Phone: 410-573-9530 Fax: 410-573-9568 | |
Dr. Christine Ajjan Laky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 185 Harry S Truman Pkwy Ste 120, Annapolis, MD 21401 Phone: 410-224-4442 Fax: 410-224-8898 | |
Margaret Jessica Keith, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 410-571-9700 | |
Elizabeth T. Greeley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 820 Bestgate Rd, Suites 2c & 2d, Annapolis, MD 21401 Phone: 410-224-4442 Fax: 410-224-8898 | |
Mark L. Repka, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2000 Medical Pkwy, Ste 304, Annapolis, MD 21401 Phone: 410-573-9530 Fax: 410-573-9569 |